US Pharma & Biotech Cardiology - PPC Market Share Analysis October 2026

Leveraging Adthena’s Whole Market View, this analysis explores recent trends in Google Ads for the US Cardiology category from the last month. Our Data Analyst, Ask Arlo provides commentary on key findings.

Cardiology – US

Google AI Overview visibility for Pharma & Biotech Cardiology US

See how often AIOs appear and how search intent is distributed across buying signals.

See more data

AIO Frequency

How often a Google AI overview appears on search terms relevant to this category.

Frequency Percentage
Frequency 81.1783719105
18.8216280895
81%

Complex Query Frequency

A complex query is a longer, more detailed search that often contains multiple keywords, specific conditions, or multi-part questions.

Frequency Percentage
Frequency 17
83
17%

Search Intent Distribution

Breakdown of search queries by their underlying goal.

Intent Distribution
Investigational 2%
Transactional 9%
Navigational 2%
Seasonal 0%
Local 0%
Problem Solving 22%

Copyright © Adthena. All rights reserved.

Market Exposure

Share of Clicks for top 10 US Pharma & Biotech Cardiology brands

Here are the Top 10 competitors in the industry by Share of Clicks for the last month.

See more data
Share of Clicks - Last month
Share of Clicks - Last month
Domain Share of clicks
repatha.com 56.94
repathahcp.com 17.97
telyrx.com 10.26
goodrx.com 3.39
bmscustomerconnect.com 2.49
leqviohcp.com 1.63
lipitor.com 1.2
vyndamax.com 1.17
nexlizethcp.com 0.61
leqvio.com 0.61
others 3.73
  • repatha.com - 56.94%
  • repathahcp.com - 17.97%
  • telyrx.com - 10.26%
  • goodrx.com - 3.39%
  • bmscustomerconnect.com - 2.49%
  • leqviohcp.com - 1.63%
  • lipitor.com - 1.2%
  • vyndamax.com - 1.17%
  • nexlizethcp.com - 0.61%
  • leqvio.com - 0.61%
  • others - 3.73%

Copyright © Adthena. All rights reserved.

Repatha.com dominates with 56.94% click share, followed by Repathahcp.com at 17.97%. Telyrx.com holds 10.26%, while others collectively capture 3.73%.

Market Exposure

Share of Spend for the top 10 US Pharma & Biotech Cardiology brands

Curious about your market position? Here you can see the Top 10 competitors in the industry by Share of Spend for the last month. 

See more data
Share of Spend - Last Month
Share of Spend - Last Month
Date repatha.com repathahcp.com telyrx.com leqviohcp.com goodrx.com vyndamax.com leqvio.com nexlizethcp.com bmscustomerconnect.com vyndamax.pfizerpro.com
2026/10/01 39.69% 39.27% 3.59% 1.81% 5.46% 1.44% 0.21% 1.29% 1.33% 0.86%
2026/10/02 42.97% 40.55% 1.64% 3.2% 1.91% 1.96% 0.78% 1.13% 1.35% 0.81%
2026/10/03 50.12% 30.26% 5.1% 2.17% 2.92% 1.49% 0.37% 1.1% 1% 0.54%
2026/10/04 53.11% 31.66% 3.93% 2.81% 1.64% 1.6% 0.58% 0.69% 0.85% 0.5%
2026/10/05 59.15% 27.86% 2.39% 1.72% 2.57% 1.54% 0.51% 0.22% 1% 0.69%
2026/10/06 54.73% 29.68% 8% 0.63% 0.61% 1.82% 0.7% 0.16% 1.24% 0.75%
2026/10/07 50.51% 25.43% 15.4% 0.8% 1.74% 1.51% 0.35% 0.34% 1.09% 0.67%
2026/10/08 49.26% 26.39% 14.89% 0.6% 1.21% 1.58% 0.29% 0.81% 1.04% 0.77%
2026/10/09 45.97% 27.13% 15.38% 0.7% 2.43% 1.47% 1.06% 0.91% 1.42% 0.83%
2026/10/10 52.14% 31.9% 5.24% 0.89% 1.42% 1.57% 0.96% 0.65% 1.31% 0.73%
2026/10/11 49.68% 31.44% 8.23% 0.8% 0.85% 1.36% 0.9% 0.24% 0.98% 0.64%
2026/10/12 60.15% 26.47% 4.85% 0.79% 1.13% 1.56% 0.24% 0.34% 1.12% 0.6%
2026/10/13 54.83% 26.08% 6.07% 2.08% 3.09% 1.73% 0.36% 0.44% 1.05% 0.81%
2026/10/14 55.77% 23.71% 5.29% 4.13% 1.33% 1.59% 0.38% 1.11% 1.13% 0.61%
2026/10/15 56% 26.16% 5.89% 2.13% 0.67% 1.58% 0.16% 0.71% 1.17% 0.71%
2026/10/16 57.92% 26.08% 3.22% 1.97% 0.54% 1.54% 0.52% 1.58% 1.22% 0.65%
2026/10/17 50.69% 25.24% 10.22% 4.1% 1.14% 1.43% 0.59% 1.21% 1% 0.56%
2026/10/18 53.12% 26.53% 7.54% 3.26% 0.96% 1.39% 1.07% 0.66% 1.03% 0.54%
2026/10/19 56.08% 25% 7.94% 2.42% 1.04% 1.54% 0.32% 0.81% 1.15% 0.68%
2026/10/20 59.11% 26% 3.48% 2.29% 1.87% 1.49% 0.69% 0.52% 1.14% 0.8%
2026/10/21 59.48% 25.26% 2.82% 2.78% 1.16% 1.28% 0.53% 0.72% 1.13% 0.7%
2026/10/22 59.98% 25.06% 1.15% 1.41% 2.38% 1.5% 0.67% 0.87% 1.07% 0.87%
2026/10/23 59.63% 24.7% 2.93% 1.14% 2.53% 1.53% 0.66% 0.56% 0.91% 0.87%
2026/10/24 50.99% 24.85% 10.35% 1.59% 2.9% 1.35% 0.38% 0.74% 0.78% 0.72%
2026/10/25 51.34% 25.89% 8.67% 2.3% 1.72% 1.33% 0.48% 0.43% 0.91% 0.61%
2026/10/26 55.79% 22.71% 5.82% 1.58% 2.12% 1.32% 0.64% 0.66% 0.8% 0.67%
2026/10/27 57.59% 22.59% 5.02% 2.23% 1.85% 1.28% 0.8% 0.69% 0.85% 0.61%
2026/10/28 60.3% 24.2% 2.84% 2.12% 0.48% 1.41% 0.76% 0.33% 0.97% 0.69%
2026/10/29 61.14% 23.78% 3.88% 1.49% 1.53% 1.28% 1.36% 0.29% 0.95% 0.58%
2026/10/30 59.31% 23.89% 3.38% 1.97% 3.08% 1.42% 0.86% 0.64% 1.04% 0.58%
2026/10/31 55.48% 21.22% 8.62% 2.67% 2.16% 1.54% 1.27% 0.91% 0.82% 0.62%
  • repatha.com
  • repathahcp.com
  • telyrx.com
  • leqviohcp.com
  • goodrx.com
  • vyndamax.com
  • leqvio.com
  • nexlizethcp.com
  • bmscustomerconnect.com
  • vyndamax.pfizerpro.com

Copyright © Adthena. All rights reserved.

Repatha.com led October with a steady rise, peaking mid-month. Repathahcp.com saw a decline, while Telyrx.com fluctuated. Leqviohcp.com and Goodrx.com had minor variations. Vyndamax.com remained stable. The month ended with Repatha.com dominating.

Market Exposure

Competitor Count for US Pharma & Biotech Cardiology

Ever wondered how many competitors you’re up against in your industry? Well look no further, here we can see the number of advertisers bidding over the last month. 

See more data
Competitor Count - Last month
Competitor Count - Last month
Date Competitor Count
2026/10/01 39
2026/10/02 43
2026/10/03 45
2026/10/04 41
2026/10/05 46
2026/10/06 43
2026/10/07 41
2026/10/08 44
2026/10/09 42
2026/10/10 41
2026/10/11 42
2026/10/12 43
2026/10/13 43
2026/10/14 44
2026/10/15 43
2026/10/16 40
2026/10/17 44
2026/10/18 42
2026/10/19 43
2026/10/20 42
2026/10/21 42
2026/10/22 42
2026/10/23 45
2026/10/24 44
2026/10/25 44
2026/10/26 44
2026/10/27 44
2026/10/28 44
2026/10/29 44
2026/10/30 43
2026/10/31 40

Copyright © Adthena. All rights reserved.

October saw a dynamic fluctuation in distinct advertisers, peaking at 46 on the 5th. The month concluded with a slight dip to 40.

Campaign Efficiency

Market Loss & Market Gains for US Pharma & Biotech Cardiology

Here we’re looking at the Top 10 biggest industry movers by market share gains and losses for the last 30 days.

See more data
Market Loss & Market Gains - Last month
Market Loss & Market Gains - Last month
Name Market Trend
repatha.com 2.73%
goodrx.com 0.9%
lipitor.com 0.67%
veltassa.com 0.51%
prevention.com 0.27%
vyndamax.com -0.11%
tryngolzahcp.com -0.11%
bmscustomerconnect.com -0.17%
repathahcp.com -1.71%
telyrx.com -4.1%

Copyright © Adthena. All rights reserved.

Telyrx.com saw a significant drop of 4.1%, while Repatha.com surged by 2.73%. Goodrx.com gained 0.9%, contrasting with repathahcp.com’s 1.71% decline.

Campaign Efficiency

US Pharma & Biotech Cardiology Share of Impressions

Take a look at the Top 10 competitors in the industry by Share of Impressions over the last month.

See more data
Date repatha.com repathahcp.com telyrx.com goodrx.com leqviohcp.com leqvio.com nexlizethcp.com vyndamax.com bmscustomerconnect.com lipitor.com
2026/10/01 17.9% 44.69% 12.62% 6.4% 2.86% 0.29% 1.99% 0.82% 1.38% 4.41%
2026/10/02 22.55% 50.38% 3.78% 5.18% 5.22% 1.18% 1.74% 1.21% 1.5% 0.03%
2026/10/03 24.55% 35.22% 14.45% 8.57% 3.56% 0.59% 1.94% 0.85% 1.02% 3.48%
2026/10/04 27.69% 40.42% 11.2% 6.16% 5% 0.77% 1.41% 0.98% 0.9% 0.01%
2026/10/05 34% 39.88% 7.6% 5.89% 3.71% 1.05% 0.48% 1.08% 1.25% 0.07%
2026/10/06 27.94% 36.44% 23.74% 0.71% 1.03% 3.42% 0.42% 1.11% 1.42% 0.01%
2026/10/07 22.85% 27.75% 39.75% 1.63% 1.09% 0.64% 0.51% 0.81% 1.02% 0.01%
2026/10/08 22.99% 28.07% 38.41% 0.59% 1.04% 0.52% 1.11% 0.83% 0.99% 0.01%
2026/10/09 21.35% 28.31% 36.73% 3.52% 0.96% 1.59% 1.19% 0.75% 1.31% 0.03%
2026/10/10 27.12% 41.84% 14.72% 1.5% 1.58% 1.61% 1.28% 1% 1.51% 0.01%
2026/10/11 22.5% 36.23% 22.17% 3.76% 1.15% 1.45% 0.43% 0.75% 1.02% 5.99%
2026/10/12 34.42% 35.83% 17.63% 0.86% 1.49% 0.38% 0.66% 1.05% 1.41% 0.02%
2026/10/13 27.47% 31.11% 19.08% 9.74% 3.29% 0.62% 0.78% 1% 1.17% 0.02%
2026/10/14 31.03% 31.86% 15.79% 1.33% 6.63% 0.79% 1.92% 1.03% 1.39% 0.02%
2026/10/15 29.21% 32.9% 16.55% 0.5% 3.89% 0.25% 1.07% 0.97% 1.32% 6.62%
2026/10/16 33.03% 36.17% 12.35% 0.7% 3.54% 1.01% 2.51% 1.06% 1.5% 0.02%
2026/10/17 26.42% 30.98% 24.67% 0.67% 6.55% 0.89% 1.79% 0.86% 1.09% 0.02%
2026/10/18 27.04% 32.16% 21.23% 1% 5.16% 1.59% 1.17% 0.83% 1.13% 3.41%
2026/10/19 29.99% 32.08% 23.33% 0.59% 4.1% 0.6% 1.53% 0.94% 1.25% 0.05%
2026/10/20 34.38% 35.32% 10.65% 5.53% 3.84% 1.17% 1.07% 0.98% 1.42% 0.02%
2026/10/21 35.59% 33.75% 7.39% 1.59% 4.55% 0.83% 1.21% 0.83% 1.33% 6.78%
2026/10/22 37.92% 34.96% 4.22% 5.39% 2.51% 1.32% 1.76% 1.01% 1.36% 0.07%
2026/10/23 36.75% 35.2% 8.81% 2.35% 2.04% 1.26% 1.11% 1.05% 1.17% 0.15%
2026/10/24 25.84% 28.63% 27.18% 4.24% 2.54% 0.69% 1.24% 0.76% 0.8% 0.1%
2026/10/25 25.15% 29.46% 23.49% 5.45% 3.11% 0.72% 0.69% 0.72% 0.91% 4.39%
2026/10/26 31.33% 28.02% 17.07% 3.56% 2.61% 0.95% 1.23% 0.79% 0.9% 4.93%
2026/10/27 32.73% 27.85% 13.34% 4.82% 3.31% 1.11% 1.22% 0.76% 0.94% 5.31%
2026/10/28 39.06% 34.25% 7.49% 0.55% 3.72% 1.42% 0.7% 0.97% 1.28% 0.12%
2026/10/29 37.48% 31.43% 12.19% 3.07% 2.68% 3.67% 0.56% 0.83% 1.18% 0.02%
2026/10/30 36.08% 30.83% 9.56% 8.58% 3.35% 1.58% 1.12% 0.9% 1.2% 0.02%
2026/10/31 32.52% 24.87% 21.53% 4.61% 3.97% 1.83% 1.37% 0.89% 0.84% 0.01%
  • repatha.com
  • repathahcp.com
  • telyrx.com
  • goodrx.com
  • leqviohcp.com
  • leqvio.com
  • nexlizethcp.com
  • vyndamax.com
  • bmscustomerconnect.com
  • lipitor.com

Copyright © Adthena. All rights reserved.

In October 2026, repatha.com saw a steady rise in impression share, peaking at 39.06% on the 28th. Meanwhile, repathahcp.com fluctuated, ending at 24.87%. Telyrx.com experienced a mid-month surge, closing at 21.53%. Goodrx.com and leqviohcp.com maintained low shares, while lipitor.com had sporadic spikes.

Campaign Efficiency

Google Text Ad Copy Insights & Creative Trends for US Pharma & Biotech Cardiology

Ever wondered how your rivals’ ads are doing? Here we can see the top-performing ads in the industry over the last month.

See more data
Google Text Ad Copy Insights & Creative Trends for US Pharma & Biotech Cardiology - Last month
  1. 1
    Rosuvastatin 2026 Prices, Coupons & Savings Tips - GoodRx https://www.goodrx.com/

    Use GoodRx® to save up to 80%. Getting your medication should never be a financial burden. We...

  2. 2
    Cardiologists at Mayo Clinic https://www.mayoclinic.org

    Top Cardiologists, Mayo Clinic — Cardiovascular Care With The Compassion, Respect & Personalized Attention You Deserve. Customize Your Heart Treatment Plan with Top-ranked Cardiologists and Cardiac Surgeons.

  3. 3
    Cardiologists At Northwell https://www.northwell.edu

    Schedule An Appointment Today — See New York's Most Experienced Heart Team. Contact Us Today! No Need to Travel Far. Now Offering World-Class Cardiology Care, Right In Your Area. Groundbreaking Procedures. World-Renowned Experts. Advanced Treatments. Virtual Appointments.

  4. 4
    Repatha® (evolocumab) - Official Site For Patients https://www.repatha.com/

    Visit the Official Patient Website for Product Information About Repatha

  5. 5
    Repatha® (evolocumab) - Dosing & Administration https://www.repathahcp.com/

    Learn More About Repatha by Visiting the Official Product Website for Physicians.

Copyright © Adthena. All rights reserved.

In the competitive landscape of Google PPC, GoodRx, Mayo Clinic, Northwell, and Repatha dominate with compelling narratives. GoodRx emphasizes affordability, offering up to 80% savings on medications. Mayo Clinic and Northwell highlight personalized, top-tier cardiology care. Repatha focuses on providing detailed product information for both patients and physicians.

Frequently Asked Questions

Customer Success Stories

the7stars achieves Google Ads PPC campaign optimization​ with Adthena

Leveraging Adthena's comprehensive insights, the7stars and their lottery client optimized their PPC campaigns and organic strategies, resulting in substantial cost savings and improved campaign performance. Read case study

Sage case study: 75% decrease in CPCs with Adthena

Sage, a leading UK software provider, used Adthena’s brand protection strategy to curb rising CPC costs. By identifying brand infringements and optimizing spend, they effectively strengthened their brand protection strategy and increased ROI.Read case study

Vodafone case study: Driving click share and sales with strategic insights from Adthena

Vodafone used Adthena data to optimize results from the launch of the Samsung S22 product. Combining Adthena’s Strategic Insights with Google Smart Bidding, Vodafone was able to maintain a flexible strategy that leveraged both manual and automated bidding. Leveraging Adthena’s Search Term Opportunities report also allowed Vodafone to implement 27 keyword terms across their business line, driving an increase in revenue at a positive ROAS.Read case study

Get the full picture

See this data specific to your brand performance

The data on this page is just a sample of the billions of data points we hold at Adthena. The insights generated by Ask Arlo, leverage real-time GenAI to answer questions about your search data.

Our search consultants can introduce you to Whole Market View data that is specific to your organization, based on the size of the relevant search term and competitor universe, and the locations that you need monitoring.